Literature DB >> 6690295

Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique.

R L Eckert, A Mullick, E A Rorke, B S Katzenellenbogen.   

Abstract

The level of estrogen receptor (ER) is a major factor regulating cell sensitivity to estrogen. We have determined the rates of ER synthesis and turnover in MCF-7 breast cancer cells by incubating cells in medium supplemented with 13C15N2H-amino acids (dense amino acids) and monitoring the shift from "old-light" (preexisting) to "new-dense" (newly synthesized) receptors by velocity sedimentation on 0.4-M KCl, 5-20% sucrose gradients prepared in buffered deuterium oxide. Cytosol or unoccupied nuclear ER prepared from control cells grown in the presence of 12C14N1H-amino acids (normal amino acids) and labeled in vitro with [125I]iodoestradiol sediments as a single, normal density peak. When cells were incubated in medium supplemented with dense amino acids for various periods of time, the [125I]iodoestradiol-labeled receptor showed a progressive shift with time to a denser species; by 3 h, a more rapidly sedimenting shoulder was observed on the normal density peak; by 6 h, 40% of the receptor sedimented at the normal density rate, with 60% at a more rapid rate; by 8 h, the predominant peak (70%) was at the more dense position, and at 15 h, all of the sites sedimented as the denser form. Thus, the magnitude of the receptor peak of normal density as a function of time in dense medium indicates that the receptor in control cells has a half-life of 4.0-4.5 h. To determine whether estradiol or the antiestrogens nafoxidine (U11,100A; (1-(2-[p-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy] ethyl)pyrrolidine hydrochloride) or CI628 affected the turnover rate of the receptor, measurements were performed on cells grown in the continuous presence of estradiol or antiestrogen (steady state conditions). Exposure of cells to 10 nM estradiol was found to increase the turnover rate of the nuclear receptor, while exposure to 200 nM nafoxidine or CI628 (alpha-(p-[2-(1-pyrrolidino)ethoxy]phenyl)4-methoxy-alpha'- nitrostillbene) did not substantially alter the turnover rate of the nuclear receptor. The half-lives of receptor were found to be 4.02 +/- 0.23 and 4.47 +/- 0.26 h for control unoccupied cytosol and nuclear receptors, 3.00 +/- 0.38 h for estradiol-occupied nuclear receptors, 4.90 +/- 0.66 h for CI628-occupied nuclear receptors, and 3.43 +/- 0.37 h for nafoxidine-occupied nuclear receptors. These results indicate that ER turns over rapidly, with a half-life of 3-5 h, in the presence or absence of estradiol or antiestrogen, and that receptor synthesis is also rapid, with the rate of appearance of newly synthesized receptor being 0.3-0.5 pmol/mg DNA . h. These rates provide the cell with the capacity for dynamic and rapid regulation of its ER levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690295     DOI: 10.1210/endo-114-2-629

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  Characterization of the pharmacophore properties of novel selective estrogen receptor downregulators (SERDs).

Authors:  Karen J Kieser; Dong Wook Kim; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

2.  Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.

Authors:  S Dauvois; P S Danielian; R White; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells.

Authors:  C Nervi; J F Grippo; M I Sherman; M D George; A M Jetten
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  In vitro and in vivo molecular imaging of estrogen receptor α and β homo- and heterodimerization: exploration of new modes of receptor regulation.

Authors:  Ramasamy Paulmurugan; Anobel Tamrazi; Tarik F Massoud; John A Katzenellenbogen; Sanjiv S Gambhir
Journal:  Mol Endocrinol       Date:  2011-11-03

5.  Phosphorylation by p38 mitogen-activated protein kinase promotes estrogen receptor α turnover and functional activity via the SCF(Skp2) proteasomal complex.

Authors:  Shweta Bhatt; Zhen Xiao; Zhaojing Meng; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

6.  Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.

Authors:  Nicholas B Berry; Meiyun Fan; Kenneth P Nephew
Journal:  Mol Endocrinol       Date:  2008-04-03

7.  Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy.

Authors:  R Jakesz; C Dittrich; J Hanusch; R Kolb; R Lenzhofer; K Moser; H Rainer; G Reiner; M Schemper; J Spona
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

8.  Steroid-regulated growth of DDT1MF-2 cells is profoundly influenced by culture conditions.

Authors:  D J Lamb; M Ray
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

9.  Inter-Individual Variation in Response to Estrogen in Human Breast Explants.

Authors:  Karen A Dunphy; Amye L Black; Amy L Roberts; Aman Sharma; Zida Li; Sneha Suresh; Eva P Browne; Kathleen F Arcaro; Jennifer Ser-Dolansky; Carol Bigelow; Melissa A Troester; Sallie S Schneider; Grace Makari-Judson; Giovanna M Crisi; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-03-09       Impact factor: 2.673

Review 10.  ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers.

Authors:  Joeli A Brinkman; Dorraya El-Ashry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-03-05       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.